These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2211452)

  • 1. Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration.
    Alarabi AA; Cars O; Danielson BG; Salmonson T; Wikström B
    J Antimicrob Chemother; 1990 Jul; 26(1):91-8. PubMed ID: 2211452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
    Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
    Keller E; Fecht H; Böhler J; Schollmeyer P
    Nephrol Dial Transplant; 1989; 4(7):640-5. PubMed ID: 2510062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
    Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
    J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using imipenem and cilastatin during continuous renal replacement therapy.
    Cotton A; Franklin BD; Brett S; Holmes A
    Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
    Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR
    Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E
    Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
    Vos MC; Vincent HH; Yzerman EP
    Intensive Care Med; 1992; 18(5):282-5. PubMed ID: 1527259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.
    Mueller BA; Scarim SK; Macias WL
    Am J Kidney Dis; 1993 Feb; 21(2):172-9. PubMed ID: 8430678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
    Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
    Tegeder I; Bremer F; Oelkers R; Schobel H; Schüttler J; Brune K; Geisslinger G
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2640-5. PubMed ID: 9420033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
    Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats.
    Albarellos GA; Denamiel GA; Montoya L; Quaine PC; Lupi MP; Landoni MF
    J Feline Med Surg; 2013 Jun; 15(6):483-7. PubMed ID: 23253883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease.
    Rolando N; Wade JJ; Philpott-Howard JN; Casewell MW; Williams R
    J Antimicrob Chemother; 1994 Jan; 33(1):163-7. PubMed ID: 8157557
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis.
    Bergan T; Michalsen H; Malmborg AS; Pedersen SS; Pressler T; Storrøsten OT; Strandvik B
    Chemotherapy; 1993; 39(6):369-73. PubMed ID: 8222862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.
    Somani P; Freimer EH; Gross ML; Higgins JT
    Antimicrob Agents Chemother; 1988 Apr; 32(4):530-4. PubMed ID: 3377464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose pharmacokinetics of imipenem-cilastatin.
    Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
    Kahan FM; Rogers JD
    Chemotherapy; 1991; 37 Suppl 2():21-5. PubMed ID: 1879183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.